ATCC® HepatoXcell™: The Solution for Your Predictive Drug Development and Toxicity Testing
Primary human hepatocytes are considered the gold standard for in vitro liver models due to their high predictive value in drug metabolism and toxicity studies. They can provide early insights into how a drug will behave in the human body, potentially reducing the risk of adverse effects in clinical trials. ATCC® hepatocytes are meticulously isolated and characterized to ensure the highest quality and performance for your drug development needs. Learn more about ATCC® HepatoXcell™ at https://www.atcc.org/hepatoxcell